Key Highlights

● Cencora, Inc. (NYSE:COR) appointed former Ryder System CEO Robert Sanchez to its board effective October 1, 2026.

● The appointment expands Cencora's board from ten members to eleven, per a September 25 8-K.

● Sanchez led Ryder as CEO from 2013 through his recent retirement after two decades at the company.

● The filing states Sanchez has not yet been assigned to any board committee.

Cencora, Inc. (NYSE:COR) appointed Robert E. Sanchez, the former chairman and CEO of Ryder System, to its Board of Directors effective October 1, 2026, expanding the board from ten members to eleven, according to an 8-K filed September 25. The pharmaceutical-solutions company said Sanchez has not yet been assigned to any board committee. Cencora will pay him the same compensation as its other non-employee directors, and the company announced the appointment in a press release the same day the 8-K was filed.

Two Decades Rising Through Ryder

Sanchez recently retired as chief executive of Ryder System, the transportation and logistics company, after two decades there. He rose through progressively senior roles including president and chief operating officer, president of global fleet management solutions, and executive vice president and chief financial officer, before becoming CEO in 2013 and later serving as executive chair through his departure. He currently serves on the board of Texas Instruments and is a Trustee at the University of Miami, where he also earned his undergraduate degree; he holds an MBA from the Wharton School.

Over his two decades at Ryder, Sanchez oversaw the company's transition from a traditional truck-leasing Business toward a broader supply-chain and logistics-solutions provider, experience the company's leaders framed as directly relevant to Cencora's own distribution-heavy operations. Cencora board chair Mark Durcan said in the company's press release that "Robert's experience as a public-company CEO, including his deep understanding of logistics and Supply chains, will complement the Board's skill set," while president and CEO Robert P. Mauch said his "breadth of experience across operations, finance and technology will add valuable insight as we advance Cencora's priorities."

Compensation and Disclosure Details

The 8-K states there are no arrangements or understandings between Sanchez and any other person regarding his appointment, no family relationships with other directors or officers, and no transactions requiring disclosure under Item 404(a) of Regulation S-K. His cash compensation will be paid quarterly, and his non-employee director annual Equity award will be pro-rated from the October 1 effective date through Cencora's 2027 annual meeting.

The specific dollar terms are described in the company's proxy statement filed with the SEC on January 22, 2026, which the 8-K references rather than restates. The filing does not disclose whether the board expects to name Sanchez to a committee shortly after his October 1 start date or wait until a later board meeting to make those assignments.

Cencora's Business

Cencora describes itself as a global pharmaceutical solutions organization that helps facilitate market access to therapies and supports healthcare delivery across the pharmaceutical value chain. The company says it ranks as the tenth-largest company domestically and sixteenth-largest globally by Revenue among Fortune 500 companies, with more than $300 billion in annual revenue.

Sanchez's logistics and supply-chain background from Ryder is a natural fit for a company whose core business involves distributing pharmaceuticals and healthcare products through complex supply networks, though the filing does not explicitly state that rationale beyond the general qualifications cited in the press release. Cencora's business involves distributing pharmaceuticals, specialty drugs and related products to pharmacies, hospitals, physician practices and other providers, a network that depends heavily on efficient logistics and Warehousing not unlike the fleet and supply-chain systems Sanchez managed at Ryder.

Committee Placement Still to Come

Cencora's January 22, 2026 proxy statement, cited in the filing, details the specific non-employee director compensation figures Sanchez will receive. The filing says Sanchez has not yet been named to any board committee; future disclosures may specify committee assignments. The appointment is effective October 1, 2026, with his initial term running through Cencora's 2027 annual meeting of stockholders, when shareholders will have their first opportunity to vote on his election.